Ambetter Clinical Coverage/Medical Policy Updates
Ambetter from Arkansas Health & Wellness updates a select number of clinical coverage policies each month, ensuring the reviewal of all policies on an annual basis.
V1.2025 CG Testing: Aortopathies and Connective Tissue Disorders (PDF)
V1.2025 CG Testing: Cardiac Disorders (PDF)
V1.2025 CG Testing: Dermatologic Conditions (PDF)
V1.2025 CG Testing: Epilepsy, Neurodegenerative, and Neuromuscular Conditions (PDF)
V1.2025 CG Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (PDF)
V1.2025 CG Testing: Eye Disorders (PDF)
V1.2025 CG Testing: General Approach to Genetic and Molecular Testing (PDF)
V1.2025 CG Testing: Hearing Loss (PDF)
V1.2025 CG Testing: Hematologic Conditions Non-Cancerous (PDF)
V1.2025 CG Testing: Hereditary Cancer Susceptibility (PDF)
V1.2025 CG Testing: Immune, Autoimmune, and Rheumatoid Disorders (PDF)
V1.2025 CG Testing: Kidney Disorders (PDF)
V1.2025 CG Testing: Lung Disorders (PDF)
V1.2025 CG Testing: Metabolic, Endocrine, and Mitochondrial Disorders (PDF)
V1.2025 CG Testing: Prenatal Cell-Free DNA Testing (PDF)
V1.2025 CG Oncology: Algorithmic Testing (PDF)
V1.2025 CG Oncology: Cancer Screening (PDF)
V1.2025 CG Oncology: Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy) (PDF)
V1.2025 CG Oncology: Cytogenetic Testing (PDF)
V1.2025 CG Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (PDF)
V1.2025 CG Testing: Preimplantation Genetic Testing (PDF)
V1.2025 CG Testing: Prenatal and Preconception Carrier Screening (PDF)
V1.2025 CG Testing: Prenatal Diagnosis (via Amniocentesis, CVS, or PUBS) and Pregnancy Loss (PDF)
V2.2024 CG Testing: Skeletal Dysplasia and Rare Bone Disorders (PDF)
V1.2025 CG Testing: Gastroenterologic Disorders Non-Cancerous (PDF)
V1.2025 CG Testing: Aortopathies and Connective Tissue Disorders (PDF)
2025 CG - Oncology Cancer Screening (PDF)
CG Pharmacogenetics 2025.1 version b - cg pharmacogenetics 2025.1 version b (PDF)
CP.MP.37 - Bariatric Surgery (PDF)
CP.MP.101 - Donor Lymphocyte Infusion (PDF)
CP.MP.160 - Implantable Wireless Pulmonary Artery Pressure Monitoring (PDF)
CP.MP.170 - Nerve Blocks and Neurolysis for Pain Management (PDF)
CP.MP.246 - Pediatric Kidney Transplant (PDF)
CP.MP.163 - Total Parenteral Nutrition and Intradialytic Parenteral Nutrition (PDF)
CP.MP.62 - Hyperhidrosis Treatments (PDF)
CP.MP.70 - Proton and Neutron Beam Therapies (PDF)
CP.MP.142 - Urinary Incontinence Devices and Treatments (PDF)
CP.MP.180 - Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (PDF)
CP.MP.97 - Testing select GU conditions (PDF)
CP.MP.113 - Holter monitors (PDF)
CP.MP.121 - Homocysteine testing (PDF)
CP.BH.104 Applied Behavior Analysis (PDF)
CP.BH.105 Applied Behavioral Analysis Documentation Requirements (PDF)
CP.MP.82 NICU Apnea Bradycardia Guidelines (PDF)
CP.MP.102 Pancreas Transplantation (PDF)
CP.MP.162 Tandem Transplant (PDF)
CP.MP.163 Total Parenteral Nutrition and Intradialytic Parenteral Nutrition (PDF)
CP.MP.40 Gastric Electrical Stimulation (PDF)
CP.MP.55 - Assisted Reproductive Technology (PDF)
CP.MP.57 - Lung Transplantation (PDF)
CP.MP.69 - Intensity-Modulated Radiotherapy (PDF)
CP.MP.132 - Heart-Lung Transplant (PDF)
CP.MP.176 - Outpatient Cardiac Rehabilitation (PDF)
CP.BH.200 - Transcranial Magnetic Stimulation for Treatment of Major Depression (PDF)